Live Breaking News & Updates on News Ratings For Fusion Pharmaceuticals Daily

Stay updated with breaking news from News ratings for fusion pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avidity Partners Management LP Has $62.47 Million Stock Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Avidity Partners Management LP lifted its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 12.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,500,328 shares of the company’s stock after buying an additional 718,478 shares during the quarter. Fusion Pharmaceuticals […] ....

China , Canada , United-states , New-york , William-blair , Quarter-for-fusion-pharmaceuticals , News-ratings-for-fusion-pharmaceuticals-daily , Fusion-pharmaceuticals-stock-performance , Fusion-pharmaceuticals-inc , Fusion-pharmaceuticals , Exchange-commission , York-state-common-retirement-fund

Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase

Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Wellington , New-zealand-general , New-zealand , Raymond-james , Nasdaq , Jennison-associates , News-ratings-for-fusion-pharmaceuticals-daily , Wellington-management-group , Institutional-trading-of-fusion-pharmaceuticals , Fusion-pharmaceuticals-inc

Head to Head Comparison: Fusion Pharmaceuticals (NASDAQ:FUSN) vs. Aura Biosciences (NASDAQ:AURA)

Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report) and Aura Biosciences (NASDAQ:AURA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Risk & Volatility Fusion Pharmaceuticals has a […] ....

United-states , Canada , Massachusetts , Boston , Fusion-pharmaceuticals , News-ratings-for-fusion-pharmaceuticals-daily , Astrazeneca-united-kingdom , Fusion-pharmaceuticals-inc , Aura-biosciences-inc , Get-free-report , Aura-biosciences

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Analysts

Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have earned a consensus rating of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat reports. Thirteen equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month […] ....

New-york , United-states , China , Canada , Raymond-james , William-blair , Leerink-partnrs , Royal-bank , Fusion-pharmaceuticals-inc , Fusion-pharmaceuticals , Fusion-pharmaceuticals-stock-performance , Institutional-investors-weigh-in-on-fusion-pharmaceuticals

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Brokerages

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

China , New-york , United-states , Canada , Raymond-james , Nasdaq , Fusion-pharmaceuticals-stock-performance , York-state-common-retirement-fund , Tower-research-capital , China-universal-asset-management-co , Fusion-pharmaceuticals-company-profile , News-ratings-for-fusion-pharmaceuticals-daily